These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33523597)
21. Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients. Giraud EL; Jessurun NT; van Hunsel FPAM; van Puijenbroek EP; van Tubergen A; Ten Klooster PM; Vonkeman HE Expert Opin Drug Saf; 2020 Dec; 19(12):1617-1624. PubMed ID: 32990050 [TBL] [Abstract][Full Text] [Related]
22. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
23. Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically. Borrega R; Cruz JP; Taylor P; Goncalves J BioDrugs; 2019 Dec; 33(6):683-691. PubMed ID: 31595484 [TBL] [Abstract][Full Text] [Related]
24. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database. Impicciatore P; Mucci M Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409 [TBL] [Abstract][Full Text] [Related]
25. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Wallerstedt SM; Brunlöf G; Sundström A Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827 [TBL] [Abstract][Full Text] [Related]
26. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Katusiime B; Semakula D; Lubinga SJ Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036 [TBL] [Abstract][Full Text] [Related]
27. PREPARING FOR VANESSA'S LAW: COLLABORATION BETWEEN THE MEDICAL RECORDS AND PHARMACY DEPARTMENTS AT A CANADIAN HOSPITAL CENTER. Rault P; Necsoiu D; Desjardins I; Lebel D; Bussières JF J Popul Ther Clin Pharmacol; 2019 Jul; 26(2):e5-e13. PubMed ID: 31577080 [TBL] [Abstract][Full Text] [Related]
28. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Inch J; Watson MC; Anakwe-Umeh S Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729 [TBL] [Abstract][Full Text] [Related]
29. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. Brvar M; Fokter N; Bunc M; Mozina M BMC Clin Pharmacol; 2009 May; 9():8. PubMed ID: 19409112 [TBL] [Abstract][Full Text] [Related]
30. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre. Jonville-Béra AP; Saissi H; Bensouda-Grimaldi L; Beau-Salinas F; Cissoko H; Giraudeau B; Autret-Leca E Drug Saf; 2009; 32(5):429-40. PubMed ID: 19419237 [TBL] [Abstract][Full Text] [Related]
31. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Aagaard L; Nielsen LH; Hansen EH Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778 [TBL] [Abstract][Full Text] [Related]
32. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]
33. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases. Patel TK; Bhabhor PH; Desai N; Shah S; Patel PB; Vatsala E; Panigrahi S Asian J Psychiatr; 2015 Oct; 17():42-9. PubMed ID: 26216702 [TBL] [Abstract][Full Text] [Related]
34. Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United States. Aagaard L; Hansen EH Curr Drug Saf; 2013 Jul; 8(3):162-8. PubMed ID: 23914751 [TBL] [Abstract][Full Text] [Related]
35. Patients' experiences on adverse drug reactions reporting: a qualitative study. Al Dweik R; Yaya S; Stacey D; Kohen D Eur J Clin Pharmacol; 2020 Dec; 76(12):1723-1730. PubMed ID: 32661571 [TBL] [Abstract][Full Text] [Related]
36. Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions. Scholl JHG; van Hunsel FPAM; Hak E; van Puijenbroek EP Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1283-1289. PubMed ID: 31189217 [TBL] [Abstract][Full Text] [Related]
37. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting. Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655 [TBL] [Abstract][Full Text] [Related]
38. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Sullivan KM; Spooner LM Am J Health Syst Pharm; 2008 Jun; 65(12):1177-9. PubMed ID: 18541689 [TBL] [Abstract][Full Text] [Related]
39. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543 [TBL] [Abstract][Full Text] [Related]
40. [Adverse drug reaction reports in Iceland from 2013 to 2016. A comparison with other Nordic countries]. Jonsdottir SS; Olafsdottir SM; Gudmundsdottir H Laeknabladid; 2017 Jul; 103(07-08):319-323. PubMed ID: 28816174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]